Access delays in cancer medicines are costing Australia productivity, livelihoods, and lives

"When people can access effective cancer treatments in a timely way, they are more likely to be able to remain in work, care for their families, contribute to their communities and avoid costly hospitalisations,” said Medicines Australia CEO Liz de Somer …